We are live on ! Find out more
CMPI

Checkmate Pharmaceuticals, Inc. Common Stock
CMPI

Delisted

CMPI was delisted on the 27th of May, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of CMPI yet.

CMPI Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) for Q2 2022, worth a combined $0 — down 100% from $54.8M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CMPI and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $12.5M sold.

  • 0 institutional investors held Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) as of Q2 2022, down from 26 in Q1 2022.
  • Funds reported $0 of Checkmate Pharmaceuticals, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Checkmate Pharmaceuticals, Inc. Common Stock positions in Q2 2022 and 26 closed out, a net change of -26 holders.
  • The largest Checkmate Pharmaceuticals, Inc. Common Stock seller in Q2 2022 was Medicxi Ventures Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q2 2022.